Impact of obesity on children undergoing liver transplantation

André A S Dick1, James D Perkins, Austin L Spitzer

  • 1Division of Transplantation, Department of Surgery, University of Washington, Seattle, WA 98195, USA. docdre@u.washington.edu

Insights

Pediatric liver transplant survival is impacted by body mass index (BMI). Thin children face early mortality, while obese children experience increased late mortality risks following liver transplantation.

Area of Science:

  • Pediatric Surgery
  • Transplant Surgery
  • Clinical Outcomes Research

Background:

  • Liver transplantation outcomes can be affected by extremes in body mass index (BMI).
  • Pediatric liver transplant survival analyses traditionally focus on weight, not BMI-adjusted Z scores.

Purpose of the Study:

  • To investigate the association between BMI Z scores and survival rates in pediatric liver transplant recipients.
  • To identify differential mortality risks associated with underweight and overweight/obese status in pediatric liver transplant patients.

Main Methods:

  • Analysis of the United Network for Organ Sharing database (1987-2007) including 9701 pediatric primary liver transplants.
  • Stratification of patients into 5 BMI-for-age Z score categories (WHO standards).
  • Comparison of survival rates using Kaplan-Meier curves and log-rank testing.

Main Results:

  • Thin pediatric patients (Z score -2 or -3) showed significantly lower 1-year survival (84.4%) compared to normal/overweight groups (88.7%).
  • Obese pediatric patients (Z score +3) had no early survival difference, but experienced significantly lower 12-year survival (72%) versus normal/overweight groups (77%).

Conclusions:

  • Liver transplantation poses increased risks for both underweight and obese pediatric patients.
  • Underweight patients face early mortality, whereas obese patients face late mortality post-transplant.
  • Tailored transplant management strategies are needed to optimize care for pediatric patients at BMI extremes.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...